RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price was down 3.5% during trading on Wednesday . The company traded as low as GBX 1.10 ($0.01) and last traded at GBX 1.10 ($0.01). 265,996 shares changed hands during mid-day trading, an increase of 20% from the average session volume of 221,595 shares. The stock had previously closed at GBX 1.14 ($0.01).
RTW Biotech Opportunities Stock Down 3.5 %
The company has a 50 day simple moving average of GBX 1.28 and a two-hundred day simple moving average of GBX 1.41. The company has a market capitalization of £369.51 million, a P/E ratio of 2.62 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- What Are Growth Stocks and Investing in Them
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- How to Use the MarketBeat Stock Screener
- Are Tariffs Threatening Disney’s Comeback Story?
- What Are Trending Stocks? Trending Stocks Explained
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
